Stocksigma LogoStocksigma Logo

Fischer Medical Ventures Releases Preferential Issue Fund Monitoring Report

Infomerics Valuation and Rating issued its Monitoring Agency Report for Fischer Medical Ventures for the quarter ended 30th Sep'26, confirming zero

Fischer Medical Ventures Releases Preferential Issue Fund Monitoring Report

Fischer Medical Ventures Ltd 路 Others (Uncategorized) 路 14 Nov 2026, 9:17 pm

Fischer Medical Ventures Releases Preferential Issue Fund Monitoring Report Infomerics Valuation and Rating issued its Monitoring Agency Report for Fischer Medical Ventures for the quarter ended 30th Sep'26, confirming zero deviation from stated objects. Out of Rs. 358.45 crore net proceeds raised via preferential issue of equity shares and convertible warrants, the company utilized Rs. 332.56 crore through 30th Sep'26, including Rs. 51.63 crore deployed during the quarter. Growth objectives received full allocation of Rs. 268.84 crore, while Rs. 63.72 crore was utilized for general corporate purposes. The unutilized Rs. 25.89 crore remains parked in sweep-account fixed deposits.

Original exchange filing (PDF)

More announcements from Fischer Medical Ventures Ltd

All Fischer Medical Ventures Ltd announcements